Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
The Rongvaux lab, in Seattle’s Fred Hutchinson Cancer Research Center Clinical Research Division, Program in Immunology, is recruiting a Staff Scientist. The objective of the lab is to gain a better understanding of the fundamental mechanisms by which the immune system protects a host from diseases, such as infections and cancers, and to use this new knowledge to address clinically-relevant questions.
Responsibilities for this highly-skilled laboratory scientist will include: supervision of a mouse colony and mouse humanization, performing and analyzing experiments, troubleshooting technical problems, developing standard protocols and mentoring junior lab members. The successful candidate will also contribute to writing manuscripts and grant proposals, and will be in charge of the interactions with collaborating laboratories, including experiment planning.
Applicants should be highly-motivated scientists, with a PhD degree in Immunology, Molecular Biology or a closely related field, and four or more years of post-Ph.D. laboratory experience. An ideal candidate will have a working knowledge of innate immunity and cancer immunology, and experience with technologies used in the lab, including humanized mouse models, single-cell RNA sequencing and reverse genetics.
Required experience includes:
** Experience with immunology techniques (flow cytometry, ELISA, …) will be viewed as a plus.
A successful candidate will also have: